Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Meat & Livestock Australia Ltd. provides and exports red meat and livestock. It invests in world-class research, development and adoption projects to increase the productivity and profitability of Australia’s cattle, sheep and goat businesses. The company was founded in 1998 and is headquartered in North Sydney, Australia.

Guangzhou Kangrui Biological Pharmaceutical Tech Co. Ltd. is a company headquartered in China. The firm specializes in novel ophthalmic drug and treatment developments.

Beijing Molik Technology Co., Ltd., established on 2003-04-16, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Computer System Services;computer repair;selling computers,Software and Auxiliary Equipment,electronic product,Equipment,communication equipment.(Except for projects without administrative permission)(Enterprises independently choose operating projects according to law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

ECI is developing and licensing its protein technologies for use in a wide range of industries with unmet needs, including nosocomial infections, medical diagnostics, industrial chemistry and consumer goods. ECI Biotech's product pipeline currently includes a diagnostic sensor for urinary tract infections, as well as advanced wound care systems designed to provide early warning of emergent infections and to promote healing. ECI presently also has 2 corporate partnerships with Fortune 100 companies in the medical device industry.

Plex Pharmaceuticals, Inc. operates as a biotechnology company which focuses on the discovery of drug-lie small molecules for underserved needs. Its products are used in the treatment of CNS/systemic, oncology, degenerative, CNS disorders and infectious diseases. The company was founded in 2009 and is headquartered in San Diego, CA.

Industrial Research Limited (IRL) was a Crown Research Institute of New Zealand that was established in 1992 and merged into Callaghan Innovation, a new Crown entity, on 1 February 2013. IRL provided research, development and commercialisation services aimed at fostering industry development, economic growth and business expansion. It was established when the Department of Scientific and Industrial Research was disbanded and its staff and assets redistributed to form the research institutes in 1992.

Scil Proteins is a biopharmaceutical company discovering and developing Affilin® molecules and working with industry partners in the development and manufacture of protein therapeutics and diagnostics. Affilin® molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin to form highly stable molecules with strong binding specificity and low immunogenicity. Scil Proteins' discovery platform is a fully patent protected screening technology for the identification of target-specific Affilin® molecules using advanced selection systems. Scil Proteins has generated a pipeline of Affilin® therapeutics targeting cancer and other therapeutic areas. It also offers the technology to the industry for collaborative discovery and development partnerships. With a longstanding expertise in protein production and development, Scil Proteins also offers GMP contract biomanufacturing and process development to biotech and pharma companies. Scil Proteins is a well-established private company located in Halle, Germany.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Navigo Proteins GmbH is a German private company located in Halle that develops affilin molecules protein therapeutics and diagnostic. Henning Afflerbach has been the CEO of the firm since 2013.\nThe company says this about itself: Navigo Proteins is a premier protein engineering company developing affinity ligands, based on its proprietary platform of selected, small, and stable, yet highly engineerable scaffold proteins. These ligands serve as target-binding proteins in biotherapeutic molecules (PRECISION TARGETING) or for commercial custom affinity purification of biologics (PRECISION CAPTURING®). Navigo’s PRECISION TARGETING unit creates proprietary Affilin® molecules based on the human Ubiquitin scaffold – a highly conserved, small (8.5kDa) and stable natural human protein. A major strength of the Precision Targeting toolbox is its modular engineerability. The target-specific Affilin® molecules can be combined with a variety of carrier units for site-specific payload coupling as well as half-life extension moieties and function-conferring effector modules to convert them into different biopharmaceutical modalities. Navigo’s ligands are currently being developed as Affilin®-drug conjugates, Affilin®-radio conjugates, Affilin® CAR-T cell therapy and can also be fused to antibodies to create robustly-to-produce bi-/multi-specific molecules (MabfilinTM/FabfilinTM).

Amano Enzyme, Inc. manufactures and distributes enzymes for pharmaceuticals, food and diagnostics. It also produces and sells feed additives, drugs, and animal drugs. The company was founded in 1899 by Ennosuke Amano and is headquartered in Nagoya, Japan.

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

Servier are driven by the belief in the excellence of their profession. Theirs is a research-based organization, fulfilling a basic need and dedicated to the future.

General Cable Superconductors Ltd., a subsidiary of Prysmian SpA, is an of New Zealand company located in Gracefield. The firm manufactures HTS roebel cables.

Polartechnics Ltd. develops, manufactures, and markets medical products for the detection of pre-cancer and cancer with a focus on cervical cancer. Its products include TruScreen, a cervical cancer screening device, and CerviScreen, a self-sampling collection device for human papillomavirus and sexually transmitted infections molecular diagnostic tests. The firm's products provide a new era in cervical screening and allow women to experience reduced pain and discomfort during gynecological procedures. The company was founded in 1987 and is headquartered in Erskineville, Australia.

Base Pair provides custom aptamer development services and catalog aptamers. Scientists at Base Pair Biotechnologies have been studying aptamers and developing them on a research basis since 2004 and began recently offering these services commercially. With a patent pending multiplexed approach we can develop custom aptamers at unprecedented time and cost.

Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT.

Vereinigte Aluminium Werke AG is a German private company, with operations in DE. The firm manufactures aluminum.